A new site of the Lebanon based pharmaceutical manufacturer Algorithm will cover the manufacturing and packaging of non-sterile oral and topical dosage forms: liquids, tablets, capsules, suppositories, granules for suspensions, creams and ointments. Find out more about the reasons why the company has chosen Ima.
“Our ultimate aim is the wellbeing of people”. Much more than a declaration of intent, this is Algorithm’s commitment day by day. After all, the Company has built its reputation around a few core values — trust and respect, ethics and integrity, responsibility and accountability, quality and excellence. These same values guide the Company to shape its future.
Based in Lebanon since 1961, the history of Algorithm is marked by a continuous improvement based on acquisitions and product launches. Indeed, Algorithm has built throughout the years strong partnerships with international pharmaceutical and biotech companies. Through its own products and its partnership with Biologix FZCo, today Algorithm is actively present in the Middle East and in North Africa.
Its portfolio consists of innovative products as well as differentiated generics, focusing mainly on the following therapeutic areas: cardio-metabolic, neurology, infectiology, rheumatology, gynecology and urology.
To fulfill the increasing demands in the Middle East and North Africa markets for the next ten years, Algorithm has decided to expand the technical capabilities by building a new production facility in Zekrit, fifteen minutes’ drive from the existing plant. The new facility is based on three pillars: quality, technology and production. “Our new facility will provide an added value for our patients by continuing on delivering quality products in compliance with the international standards,” says Elie Tabbal, Project Manager at Algorithm
This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 44569379 / Pharma & Food)